transitioning from tirzepatide to retatrutide vs for weight loss and body recomp switching to retatrutide from tirzepatide

Enobosarm appears to be the most searched for SARM (Google trends)

10.1016/0003-9861(89)90278-6 Arch

Studies of medication switching show: 80-90% of patients tolerate the switch well 10-20% experience increased side effects requiring dose adjustment Weight loss typically continues after initial adjustment period Switching from semaglutide to tirzepatide often results in additional weight loss Important Considerations: Insurance and Cost: If switching due to insurance changes, verify coverage before stopping current medication

You will also have direct access to your Felix practitioner after you've completed the visit and during your treatment plan